US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Belite Bio, Inc.

56.40

-0.8800-1.54%

Post-market: 56.400.00000.00%18:23 EDT

Volume:20.44K

Turnover:1.16M

Market Cap:1.80B

PE:-47.65

High:58.01

Open:56.76

Low:55.51

Close:57.28

Loading ...

Overview Company News Filings

Belite Bio, Inc. Appoints New Auditor

Promising Pipeline and Strategic Advancements: Marc Goodman Recommends ‘Buy’ for Belite Bio, Inc.

Belite Bio Price Target Maintained With a $100.00/Share by HC Wainwright & Co.

BUZZ-H.C. Wainwright starts coverage on Actuate Therapeutics with 'buy' rating

Belite Bio Q4 Loss Widens

MT Newswires Live

Belite Bio Q4 2024 GAAP EPS $(0.32) Misses $(0.31) Estimate, As Of December 31, 2024, The Company Had $31.7M In Cash

Belite Bio Inc: Qtrly Loss per Share $0.32

THOMSON REUTERS

Belite Bio FY Net Income USD -36.144 Million

THOMSON REUTERS

Calendar of U.S. Earnings Expected in the Week Ahead

Press Release: Belite Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website

Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results

Belite Bio to Participate in the Leerink Partners Global Healthcare Conference

Belite Bio, Inc. ADR (BLTE) Gets a Buy from Benchmark Co.

Belite Bio Shares Phase 3 Interim Results for its Stargardt Disease Trial

MT Newswires Live

Belite Bio Announces Interim Analysis Results from the Pivotal Global Phase 3 DRAGON trial of Tinlarebant in Adolescent Stargardt Disease Subjects

Belite Bio Signs Securities Purchase Deal for its American Depositary Shares, Warrants

MT Newswires Live

Belite Bio Announces Registered Direct Offering of $15 Million

THOMSON REUTERS

Belite Bio Announces Registered Direct Offering of $15 Million

Belite Bio files automatic mixed securities shelf

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BLTE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BLTE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLTE\",,,,,undefined,":{"symbol":"BLTE","market":"US","secType":"STK","nameCN":"Belite Bio, Inc.","latestPrice":56.4,"timestamp":1744920000000,"preClose":57.28,"halted":0,"volume":20440,"hourTrading":{"tag":"盘后","latestPrice":56.4,"preClose":56.4,"latestTime":"18:23 EDT","volume":27,"amount":1521.81,"timestamp":1744928591168},"delay":0,"floatShares":14286650,"shares":31837660,"eps":-1.183559,"marketStatus":"Market Closed","change":-0.88,"latestTime":"04-17 16:00:00 EDT","open":56.76,"high":58.01,"low":55.51,"amount":1156666.85512,"amplitude":0.043645,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.183559,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":1,"listingDate":1651204800000,"exchange":"NASDAQ","adjPreClose":57.28,"preHourTrading":{"tag":"盘前","latestPrice":58.7,"preClose":57.28,"latestTime":"04:08 EDT","volume":2,"amount":115.5,"timestamp":1744877318857},"postHourTrading":{"tag":"盘后","latestPrice":56.4,"preClose":56.4,"latestTime":"18:23 EDT","volume":27,"amount":1521.81,"timestamp":1744928591168},"volumeRatio":0.46744146883051507},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLTE\",,,,,undefined,":{"symbol":"BLTE","floatShares":14286650,"roa":"-20.26%","roe":"-30.60%","lyrEps":-1.183559,"volumeRatio":0.46744146883051507,"shares":31837660,"dividePrice":0,"high":58.01,"amplitude":0.043645,"preClose":57.28,"low":55.51,"week52Low":32.25,"pbRate":"12.31","week52High":86.53,"institutionHeld":0,"latestPrice":56.4,"eps":-1.183559,"divideRate":0,"volume":20440,"delay":0,"ttmEps":-1.183559,"open":56.76,"prevYearClose":63.1,"prevWeekClose":56.6,"prevMonthClose":66.22,"prevQuarterClose":66.22,"fiveDayClose":58.52,"twentyDayClose":67.73,"sixtyDayClose":58.91},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BLTE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2523463352","title":"Belite Bio, Inc. Appoints New Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2523463352","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523463352?lang=en_us&edition=fundamental","pubTime":"2025-03-29 04:37","pubTimestamp":1743194257,"startTime":"0","endTime":"0","summary":"Belite Bio, Inc. ADR ( ($BLTE) ) has shared an announcement. Belite Bio, Inc., a company involved in the biotechnology sector, has announced a chan...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/belite-bio-inc-appoints-new-auditor?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/belite-bio-inc-appoints-new-auditor?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLTE","BK4007"],"gpt_icon":0},{"id":"2520929724","title":"Promising Pipeline and Strategic Advancements: Marc Goodman Recommends ‘Buy’ for Belite Bio, Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2520929724","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520929724?lang=en_us&edition=fundamental","pubTime":"2025-03-19 15:57","pubTimestamp":1742371032,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst Marc Goodman has maintained their bullish stance on BLTE stock, giving a Buy rating yesterday. Marc Goodman has given his ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-pipeline-and-strategic-advancements-marc-goodman-recommends-buy-for-belite-bio-inc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-pipeline-and-strategic-advancements-marc-goodman-recommends-buy-for-belite-bio-inc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2520111628","title":"Belite Bio Price Target Maintained With a $100.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2520111628","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520111628?lang=en_us&edition=fundamental","pubTime":"2025-03-18 18:54","pubTimestamp":1742295240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BLTE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 18, 2025 06:54 ET (10:54 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLTE"],"gpt_icon":0},{"id":"2520615542","title":"BUZZ-H.C. Wainwright starts coverage on Actuate Therapeutics with 'buy' rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2520615542","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520615542?lang=en_us&edition=fundamental","pubTime":"2025-03-17 19:43","pubTimestamp":1742211831,"startTime":"0","endTime":"0","summary":"BUZZ-H.C. Wainwright starts coverage on Actuate Therapeutics with 'buy' rating** Brokerage H.C. Wainwright initiates coverage on biopharma firm Actuate Therapeutics ACTU.O with \"buy\" rating ** Brokerage sets PT at $20, representing more than 100% upside to the stock's last close** In a mid-stage study, co's experimental therapy for a type of pancreatic cancer improved overall survival over chemotherapy alone, with a 37% reduction in the risk of death ** Brokerage says the trial data for the therapy, elraglusib, \"positions it as a frontrunner among competition\" for pancreatic cancer treatments ** Brokerage is optimistic about ACTU because the pancreatic cancer market has a significant unmet need ** Brokerage expects elraglusib to launch in 2029 and believes ACTU has a revenue potential of nearly $600 mln by 2033** ACTU has fallen 8.9% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nL4N3Q00SZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACTU","BLTE"],"gpt_icon":0},{"id":"2520154935","title":"Belite Bio Q4 Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2520154935","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520154935?lang=en_us&edition=fundamental","pubTime":"2025-03-17 19:01","pubTimestamp":1742209274,"startTime":"0","endTime":"0","summary":"Belite Bio (BLTE) reported a Q4 net loss Monday of $0.32 per diluted share, widening from a loss of $0.25 a year earlier.Analysts polled by FactSet expected a loss of $0.31.As of the end of 2024, the company said it had a cash balance of $31.7 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2520517985","title":"Belite Bio Q4 2024 GAAP EPS $(0.32) Misses $(0.31) Estimate, As Of December 31, 2024, The Company Had $31.7M In Cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2520517985","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520517985?lang=en_us&edition=fundamental","pubTime":"2025-03-17 18:02","pubTimestamp":1742205744,"startTime":"0","endTime":"0","summary":"Belite Bio (NASDAQ:BLTE) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.31) by 3.23 percent. This is a 28 percent decrease over losses of $(0.25) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44351861/belite-bio-q4-2024-gaap-eps-0-32-misses-0-31-estimate-as-of-december-31-2024-the-company-had-31-7m-","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Belite Bio Q4 2024 GAAP EPS $(0.32) Misses $(0.31) Estimate, As Of December 31, 2024, The Company Had $31.7M In Cash","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLTE"],"gpt_icon":0},{"id":"2520517679","title":"Belite Bio Inc: Qtrly Loss per Share $0.32","url":"https://stock-news.laohu8.com/highlight/detail?id=2520517679","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520517679?lang=en_us&edition=fundamental","pubTime":"2025-03-17 18:00","pubTimestamp":1742205602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nPLXB72E93:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BLTE","BK4007"],"gpt_icon":0},{"id":"2520351755","title":"Belite Bio FY Net Income USD -36.144 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2520351755","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520351755?lang=en_us&edition=fundamental","pubTime":"2025-03-17 18:00","pubTimestamp":1742205602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nPLXB72E93:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2520889517","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2520889517","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520889517?lang=en_us&edition=fundamental","pubTime":"2025-03-17 18:00","pubTimestamp":1742205600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Bitcoin Depot Inc.                               4Q       .02   8:05 AM. ·IHS Hldg Ltd.                                    4Q       .01   6:00 AM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANRO","INO","NRXP","LEN.B","AUTL","HYPR","CAL","LVTX","SCPH","SPRY","PL","IMTX","RWAY","CMC","OSS","GLUE","OABI","DRI","BTM","BLTE","KLC","KOPN","RBOT","RANI","CNTX","SGMO","ASO","DMAC","NOA","SAIC","ABSI","LAR","STNE","MSIF","CELC","CBUS","LPRO","LQDA","FIVE","OPTN","AEVA","DERM","FLUX","BCAB","STTK","LXEO","SIG","PHUN"],"gpt_icon":1},{"id":"2520651208","title":"Press Release: Belite Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2520651208","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520651208?lang=en_us&edition=fundamental","pubTime":"2025-03-17 18:00","pubTimestamp":1742205600,"startTime":"0","endTime":"0","summary":"-- Following a pre-specified interim analysis, the Data Safety Monitoring. Board  recommended the DRAGON trial, a pivotal Phase 3 trial in. modification; trial completion expected Q4 2025 (including a three-month. -- Pivotal global Phase 3 PHOENIX trial of Tinlarebant in geographic atrophy. -- Raised $15 million in gross proceeds in a registered direct offering on. -- Conference call and webcast on Monday, March 17, 2025, at 4:30 p.m. ET. SAN DIEGO, March 17, 2025  -- Belite Bio, Inc , a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced its financial results for the fourth quarter and full-year ended December 31, 2024, and provided a business update. has been implicated in the onset and progression of STGD1,Fast Track and Rare Pediatric Disease Designations in the U.S.; Orphan. Drug Designation in the U.S., Europe, and Japan; and Sakigake (P","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2054465674.USD","LU1316542783.SGD","LU0081259029.USD","LU2250418816.HKD","LU2360106780.USD","BK4585","BLTE","LU0823421416.USD","LU1303367103.USD","BK4554","LU0127658192.USD","BK4575","LU1880398471.USD","LU2098885051.SGD","LU0390134368.USD","IE0004445239.USD","IE00BMPRXR70.SGD","LU0719512351.SGD","LU0823421333.USD","LU1989764664.SGD","BK4614","LU2458330169.SGD","BK4141","LU0198837287.USD","BK4529","BK4605","LU0823434583.USD","LU1242518857.USD","BK4573","BK4532","IE00BMPRXN33.USD","BK4612","LU1923623000.USD","BK4534","BK4543","LU2264538146.SGD","LU2458330243.SGD","IE0009356076.USD","IE00B5949003.HKD","LU0979878070.USD","LU0109392836.USD","LU1064131342.USD","BK4007","LU1852331112.SGD","LU1988902786.USD","LU0889565833.HKD","LU1880398554.USD","LU0642271901.SGD"],"gpt_icon":1},{"id":"2520517419","title":"Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website","url":"https://stock-news.laohu8.com/highlight/detail?id=2520517419","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520517419?lang=en_us&edition=fundamental","pubTime":"2025-03-17 18:00","pubTimestamp":1742205600,"startTime":"0","endTime":"0","summary":"SAN DIEGO, March  17, 2025  (GLOBE NEWSWIRE) -- Belite Bio, Inc(NASDAQ: BLTE), a San Diego based clinical stage biopharmaceutical drug development company, today announced that its annual report on Fo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/17/3043519/0/en/Belite-Bio-Announces-Availability-of-Annual-Report-on-Form-20-F-Through-Company-Website.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4585","LU1951200564.SGD","LU0823434740.USD","BK4612","LU0109392836.USD","LU1242518857.USD","LU2125154778.USD","LU0162691827.USD","LU0106831901.USD","IE00BMPRXR70.SGD","LU1162221912.USD","LU0823421416.USD","BK4543","LU0889565833.HKD","LU1201861249.SGD","LU0198837287.USD","BLTE","BK4575","LU0979878070.USD","LU1880398554.USD","LU2264538146.SGD","BK4504","LU1316542783.SGD","BK4207","LU0127658192.USD","LU2098885051.SGD","BK4141","LU0477156953.USD","LU0823434583.USD","LU0320765646.SGD","LU1852331112.SGD","LU0980610538.SGD","LU2456880835.USD","LU2417539215.USD","LU1989764664.SGD","LU1303367103.USD","BK4532","LU0648001328.SGD","LU0072461881.USD","LU0310800965.SGD","LU2125154935.USD","LU0081259029.USD","BK4554","IE00BMPRXN33.USD","LU0719512351.SGD","LU0082616367.USD","LU1803068979.SGD","LU0098860793.USD"],"gpt_icon":1},{"id":"2518769438","title":"Belite Bio to Host Webcast on March 17, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2518769438","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518769438?lang=en_us&edition=fundamental","pubTime":"2025-03-11 15:00","pubTimestamp":1741676400,"startTime":"0","endTime":"0","summary":"SAN DIEGO, March 11, 2025  -- Belite Bio, Inc , a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it will host a webcast on Monday, March 17, 2025, at 4:30 p.m. Eastern Time to discuss the Company’s financial results and provide a business update for the fourth quarter and full year ended December 31, 2024.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/belite-bio-host-webcast-march-070000620.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0642271901.SGD","BK4532","IE00BMPRXN33.USD","LU1880398554.USD","LU1242518931.SGD","LU1989764664.SGD","BK4512","BK4218","BK4181","LU1242518857.USD","LU2264538146.SGD","LU0719512351.SGD","LU2360106780.USD","BK4585","BK4612","LU1988902786.USD","LU1316542783.SGD","LU1803068979.SGD","IE0009356076.USD","BK4588","LU1064131342.USD","BK4534","BK4605","BK4573","LU0081259029.USD","HST","LU0823434740.USD","LU0823421333.USD","LU1923623000.USD","LU0056508442.USD","BK4529","BK4575","LU2098885051.SGD","LU2458330169.SGD","LU2458330243.SGD","LU1951198990.SGD","LU2054465674.USD","BK4554","LU0082616367.USD","BLTE","BK4614","LU1880398471.USD","BK4566","IE0004445239.USD","LU1303367103.USD","LU0127658192.USD","LU0390134368.USD","LU2250418816.HKD","LU0889565833.HKD"],"gpt_icon":1},{"id":"2516675759","title":"Belite Bio to Participate in the Leerink Partners Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2516675759","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516675759?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:00","pubTimestamp":1741093200,"startTime":"0","endTime":"0","summary":"SAN DIEGO, March  04, 2025  (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/04/3036463/0/en/Belite-Bio-to-Participate-in-the-Leerink-Partners-Global-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1988902786.USD","LU0056508442.USD","LU0823434583.USD","LU1242518857.USD","LU2458330243.SGD","HCSG","BK4141","LU1803068979.SGD","LU1951200564.SGD","LU0823421333.USD","LU1064131342.USD","BK4585","LU0109392836.USD","BK4007","LU2054465674.USD","LU0823421416.USD","BK4534","LU1880398471.USD","LU1951198990.SGD","IE0009356076.USD","BK4605","BK4554","BK4532","BK4543","LU1242518931.SGD","BLTE","LU1852331112.SGD","LU0198837287.USD","LU0081259029.USD","LU0642271901.SGD","LU2360106780.USD","BK4566","LU0127658192.USD","IE00B5949003.HKD","LU1303367103.USD","LU1923623000.USD","LU0082616367.USD","LU0719512351.SGD","BK4575","LU0390134368.USD","IE0004445239.USD","BK4512","BK4529","BK4137","BK4588","IE00BMPRXN33.USD","LU1880398554.USD","IE00BMPRXR70.SGD","LU0979878070.USD"],"gpt_icon":1},{"id":"2516384653","title":"Belite Bio, Inc. ADR (BLTE) Gets a Buy from Benchmark Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2516384653","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516384653?lang=en_us&edition=fundamental","pubTime":"2025-03-03 23:45","pubTimestamp":1741016730,"startTime":"0","endTime":"0","summary":"In a report released on February 28, Bruce Jackson from Benchmark Co. reiterated a Buy rating on Belite Bio, Inc. ADR (BLTE – Research Report), wit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/belite-bio-inc-adr-blte-gets-a-buy-from-benchmark-co-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/belite-bio-inc-adr-blte-gets-a-buy-from-benchmark-co-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2514858876","title":"Belite Bio Shares Phase 3 Interim Results for its Stargardt Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2514858876","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514858876?lang=en_us&edition=fundamental","pubTime":"2025-02-27 17:47","pubTimestamp":1740649667,"startTime":"0","endTime":"0","summary":"Belite Bio  said Thursday that an independent data safety monitoring board has advised continuing the phase 3 Dragon trial of Tinlarebant for adolescent Stargardt disease without altering the study's structure.The recommendation to continue followed an interim analysis after all 104 participants completed a year of treatment and is expected to finish by Q4 without an increase in sample size, the company said.Belite Bio also said Tinlarebant has shown a consistent safety profile, with no significant adverse effects reported, and most participants experienced stable vision that improved from baseline.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2514840213","title":"Belite Bio Announces Interim Analysis Results from the Pivotal Global Phase 3 DRAGON trial of Tinlarebant in Adolescent Stargardt Disease Subjects","url":"https://stock-news.laohu8.com/highlight/detail?id=2514840213","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514840213?lang=en_us&edition=fundamental","pubTime":"2025-02-27 15:00","pubTimestamp":1740639600,"startTime":"0","endTime":"0","summary":"An independent Data Safety Monitoring Board  for the Phase 3 DRAGON trial recommends trial continuation without any modifications, maintaining the sample size at 104 subjects following a planned interim efficacy analysis; trial completion expected by Q4 2025 . Tinlarebant has been granted Fast Track and Rare Pediatric Disease Designations in the U.S., Orphan Drug Designation in the U.S., Europe, and Japan, and the Pioneer Drug Designation in Japan for Stargardt disease, for which there are no approved treatments. The pivotal Phase 3 DRAGON trial is a randomized, double-masked, placebo-controlled, global and multi-center study, designed to evaluate the safety and efficacy of Tinlarebant in adolescent Stargardt disease patients. The DRAGON trial has sites in 11 jurisdictions, including the U.S., the United Kingdom, Germany, France, Belgium, Switzerland, Netherlands, China, Hong Kong, Taiwan, and Australia. The study enrolled 104 s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/belite-bio-announces-interim-analysis-070000841.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4529","BK4554","LU0081259029.USD","LU0719512351.SGD","IE0004445239.USD","LU0823421333.USD","LU2054465674.USD","IE00BMPRXR70.SGD","LU2264538146.SGD","IE00BMPRXN33.USD","LU0056508442.USD","LU1951200564.SGD","BK4007","LU1923623000.USD","LU1803068979.SGD","BK4588","LU1878469433.USD","BK4512","BK4585","LU1951198990.SGD","BK4605","LU0198837287.USD","LU2250418816.HKD","LU1242518931.SGD","LU0979878070.USD","LU1303367103.USD","LU1852331112.SGD","BK4543","LU1242518857.USD","LU0823434583.USD","BK4532","LU0642271901.SGD","LU1989764664.SGD","BK4141","LU1064131342.USD","LU0127658192.USD","BK4534","LU0823421416.USD","LU1880398471.USD","RPD","LU2458330169.SGD","LU1316542783.SGD","LU1880398554.USD","LU0889565833.HKD","LU0109392836.USD","LU2098885051.SGD","LU1988902786.USD","BLTE","LU2360106780.USD"],"gpt_icon":1},{"id":"2509242634","title":"Belite Bio Signs Securities Purchase Deal for its American Depositary Shares, Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2509242634","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509242634?lang=en_us&edition=fundamental","pubTime":"2025-02-06 17:22","pubTimestamp":1738833734,"startTime":"0","endTime":"0","summary":"Belite Bio  said late Wednesday it signed a securities purchase deal with a new healthcare investor to buy and sell 258,309 of its American depositary shares and warrants to buy equal amount of American depositary shares at $58.07 per ADS in a registered direct offering for gross proceeds of roughly $15 million.The biopharmaceutical company intends to close the offering around Friday, and plans to use the net proceeds for working capital and general corporate purposes, it added.Belite Bio's stock was down more than 1% in recent Thursday premarket activity.Price: 57.11, Change: -0.96, Percent Change: -1.65","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4117","AFG","BLTE","BK4007","BK4107"],"gpt_icon":0},{"id":"2509629128","title":"Belite Bio Announces Registered Direct Offering of $15 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2509629128","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509629128?lang=en_us&edition=fundamental","pubTime":"2025-02-06 11:35","pubTimestamp":1738812900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250206:nTUA5NY2V6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2509874294","title":"Belite Bio Announces Registered Direct Offering of $15 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2509874294","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509874294?lang=en_us&edition=fundamental","pubTime":"2025-02-06 11:35","pubTimestamp":1738812900,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Feb. 05, 2025  -- Belite Bio, Inc  , a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it has entered into a securities purchase agreement with a new, fundamental healthcare investor for the purchase and sale of 258,309 American Depositary Shares  and warrants to purchase 258,309 ADSs, at a purchase price of $58.07 per ADS and accompanying warrant, pursuant to a registered direct offering, equivalent to today’s closing price. The offering is expected to result in gross proceeds of approximately $15 million, before deducting offering expenses, as well as the potential for additional proceeds of approximately $15 million from the exercise of five-year warrants issued in the offering. The closing of the offering is expected to occur on or about February 7, 2025, subject to the satisfaction of customary closing conditions.The C","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/belite-bio-announces-registered-direct-033500124.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BLTE"],"gpt_icon":0},{"id":"2506587027","title":"Belite Bio files automatic mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2506587027","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506587027?lang=en_us&edition=fundamental","pubTime":"2025-01-28 05:10","pubTimestamp":1738012247,"startTime":"0","endTime":"0","summary":"16:06 EST Belite Bio (BLTE) files automatic mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving bre...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/belite-bio-files-automatic-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/belite-bio-files-automatic-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLTE","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BLTE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-12","symbol":"BLTE","fiscalQuarterEnding":"2024/09","expectedEps":-0.3,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.28},{"market":"US","date":"2024-05-14","symbol":"BLTE","fiscalQuarterEnding":"2024/03","expectedEps":-0.34,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":-0.33},{"market":"US","date":"2024-03-12","symbol":"BLTE","fiscalQuarterEnding":"2023/12","expectedEps":-0.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1710216000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BLTE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BLTE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.8,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1702612800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BLTE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BLTE","date":"2025-04-17","current":-50.455433,"percent":0.472067,"low":-115.314247,"twenty":-85.790487,"median":-47.146312,"eighty":-37.170114,"high":-14.956745,"avg":-56.251688,"sd":24.221297,"marketCap":1823661164},"quantilePoints":[{"date":"2022-04-29","current":-26.398656,"twenty":-21.821892,"median":-14.956745,"eighty":-14.956745,"marketCap":255169407},{"date":"2022-05-06","current":-40.308429,"twenty":-35.871261,"median":-27.657515,"eighty":-17.818469,"marketCap":389621275},{"date":"2022-05-13","current":-35.39991,"twenty":-36.668954,"median":-33.652677,"eighty":-23.826095,"marketCap":342175534},{"date":"2022-05-20","current":-32.621429,"twenty":-36.112759,"median":-33.266295,"eighty":-27.405744,"marketCap":315318733},{"date":"2022-05-27","current":-37.380865,"twenty":-36.745988,"median":-34.47375,"eighty":-30.038223,"marketCap":361323438},{"date":"2022-06-03","current":-38.461385,"twenty":-37.850894,"median":-35.39991,"eighty":-31.787884,"marketCap":371767749},{"date":"2022-06-10","current":-47.620083,"twenty":-38.810445,"median":-36.371275,"eighty":-32.168639,"marketCap":460295722},{"date":"2022-06-17","current":-74.555916,"twenty":-40.580208,"median":-36.768666,"eighty":-32.673126,"marketCap":720657483},{"date":"2022-06-24","current":-88.191056,"twenty":-58.528195,"median":-37.792492,"eighty":-32.879912,"marketCap":852454746},{"date":"2022-07-01","current":-96.963853,"twenty":-72.549235,"median":-38.332752,"eighty":-33.599043,"marketCap":937252607},{"date":"2022-07-08","current":-110.573267,"twenty":-77.365269,"median":-38.679547,"eighty":-33.64195,"marketCap":1068801195},{"date":"2022-07-15","current":-108.232139,"twenty":-87.120826,"median":-39.696266,"eighty":-34.309535,"marketCap":1046171854},{"date":"2022-07-22","current":-102.289276,"twenty":-100.472972,"median":-41.278457,"eighty":-34.967702,"marketCap":988728142},{"date":"2022-07-29","current":-86.441642,"twenty":-100.164252,"median":-58.528195,"eighty":-35.338166,"marketCap":835544908},{"date":"2022-08-05","current":-78.131924,"twenty":-97.591584,"median":-71.520167,"eighty":-35.482236,"marketCap":755223180},{"date":"2022-08-12","current":-87.565462,"twenty":-95.543741,"median":-72.600688,"eighty":-36.079095,"marketCap":736075276},{"date":"2022-08-19","current":-66.768665,"twenty":-93.315811,"median":-74.864636,"eighty":-36.460142,"marketCap":561257398},{"date":"2022-08-26","current":-75.643543,"twenty":-91.390849,"median":-75.643543,"eighty":-36.673454,"marketCap":635859622},{"date":"2022-09-02","current":-101.706101,"twenty":-95.030364,"median":-76.279604,"eighty":-36.757327,"marketCap":854941487},{"date":"2022-09-09","current":-114.249262,"twenty":-100.225996,"median":-76.845232,"eighty":-37.135985,"marketCap":960379296},{"date":"2022-09-16","current":-114.811338,"twenty":-102.848828,"median":-77.205764,"eighty":-37.627841,"marketCap":965104104},{"date":"2022-09-23","current":-109.456828,"twenty":-106.174005,"median":-77.716055,"eighty":-37.836293,"marketCap":920094096},{"date":"2022-09-30","current":-99.250718,"twenty":-106.801736,"median":-79.400575,"eighty":-38.068668,"marketCap":834301538},{"date":"2022-10-07","current":-86.234231,"twenty":-106.278454,"median":-80.156097,"eighty":-38.358478,"marketCap":724884943},{"date":"2022-10-14","current":-82.151787,"twenty":-105.832011,"median":-82.151787,"eighty":-38.461385,"marketCap":690567920},{"date":"2022-10-21","current":-90.139177,"twenty":-105.405334,"median":-84.829042,"eighty":-38.72318,"marketCap":757709921},{"date":"2022-10-28","current":-85.139662,"twenty":-104.55188,"median":-85.169245,"eighty":-39.176175,"marketCap":715684002},{"date":"2022-11-04","current":-81.826375,"twenty":-103.869533,"median":-84.873416,"eighty":-39.562487,"marketCap":687832505},{"date":"2022-11-11","current":-74.19398,"twenty":-102.848828,"median":-83.60135,"eighty":-40.063564,"marketCap":623674592},{"date":"2022-11-18","current":-79.873901,"twenty":-102.088608,"median":-82.403242,"eighty":-40.512263,"marketCap":671420016},{"date":"2022-11-25","current":-95.848682,"twenty":-101.855338,"median":-83.409061,"eighty":-41.152396,"marketCap":805704019},{"date":"2022-12-02","current":-98.570311,"twenty":-101.188152,"median":-84.60717,"eighty":-44.193289,"marketCap":828582034},{"date":"2022-12-09","current":-92.062067,"twenty":-100.28774,"median":-85.184037,"eighty":-51.983328,"marketCap":773873736},{"date":"2022-12-16","current":-89.784182,"twenty":-99.761792,"median":-85.790487,"eighty":-61.824383,"marketCap":754725832},{"date":"2022-12-23","current":-91.38166,"twenty":-98.978555,"median":-86.012359,"eighty":-68.360546,"marketCap":768154233},{"date":"2022-12-30","current":-89.177732,"twenty":-98.392813,"median":-86.135345,"eighty":-70.79982,"marketCap":749628014},{"date":"2023-01-06","current":-88.719196,"twenty":-97.682823,"median":-86.204648,"eighty":-71.005634,"marketCap":745773565},{"date":"2023-01-13","current":-84.31134,"twenty":-97.564491,"median":-86.204648,"eighty":-72.034701,"marketCap":708721128},{"date":"2023-01-20","current":-87.535879,"twenty":-97.44616,"median":-86.234231,"eighty":-72.446328,"marketCap":735826602},{"date":"2023-01-27","current":-88.600865,"twenty":-97.085248,"median":-86.657722,"eighty":-72.590397,"marketCap":744778869},{"date":"2023-02-03","current":-88.674822,"twenty":-96.971566,"median":-87.24005,"eighty":-73.875322,"marketCap":745400554},{"date":"2023-02-10","current":-91.706776,"twenty":-96.947371,"median":-87.335437,"eighty":-74.241312,"marketCap":770887161},{"date":"2023-02-17","current":-93.363716,"twenty":-96.947371,"median":-87.496436,"eighty":-74.253145,"marketCap":784815396},{"date":"2023-02-24","current":-94.192038,"twenty":-97.132581,"median":-87.565462,"eighty":-74.434808,"marketCap":791778270},{"date":"2023-03-03","current":-95.22744,"twenty":-97.363328,"median":-87.632615,"eighty":-74.92638,"marketCap":800481863},{"date":"2023-03-10","current":-94.961194,"twenty":-97.42841,"median":-87.920457,"eighty":-75.189222,"marketCap":798243796},{"date":"2023-03-17","current":-84.222592,"twenty":-97.363328,"median":-87.934805,"eighty":-75.466045,"marketCap":707975105},{"date":"2023-03-24","current":-79.903484,"twenty":-97.132581,"median":-87.713377,"eighty":-75.714542,"marketCap":671668690},{"date":"2023-03-31","current":-88.452654,"twenty":-96.979278,"median":-87.632615,"eighty":-75.840972,"marketCap":743533012},{"date":"2023-04-06","current":-57.292558,"twenty":-96.963853,"median":-87.632615,"eighty":-75.761875,"marketCap":724636269},{"date":"2023-04-13","current":-57.666119,"twenty":-96.947371,"median":-87.572858,"eighty":-75.049868,"marketCap":729361076},{"date":"2023-04-21","current":-58.76284,"twenty":-96.780899,"median":-87.496436,"eighty":-73.875322,"marketCap":743232403},{"date":"2023-04-28","current":-56.892666,"twenty":-96.263671,"median":-87.36502,"eighty":-70.954181,"marketCap":719578441},{"date":"2023-05-04","current":-56.842842,"twenty":-95.967014,"median":-87.328799,"eighty":-59.191996,"marketCap":718948267},{"date":"2023-05-12","current":-53.472161,"twenty":-95.706684,"median":-87.269633,"eighty":-58.621736,"marketCap":676315896},{"date":"2023-05-19","current":-31.356182,"twenty":-95.434521,"median":-86.850673,"eighty":-57.749299,"marketCap":579242744},{"date":"2023-05-26","current":-31.817882,"twenty":-95.280689,"median":-86.441642,"eighty":-56.991071,"marketCap":587771741},{"date":"2023-06-02","current":-23.242075,"twenty":-95.24519,"median":-86.204648,"eighty":-56.754266,"marketCap":429350860},{"date":"2023-06-09","current":-20.2105,"twenty":-95.211949,"median":-86.135345,"eighty":-55.086075,"marketCap":373348574},{"date":"2023-06-16","current":-19.595992,"twenty":-95.109539,"median":-85.997567,"eighty":-51.074789,"marketCap":361996759},{"date":"2023-06-23","current":-16.755597,"twenty":-94.98486,"median":-85.790487,"eighty":-40.900274,"marketCap":309526148},{"date":"2023-06-30","current":-20.388025,"twenty":-94.961194,"median":-85.31716,"eighty":-39.361819,"marketCap":376627987},{"date":"2023-07-07","current":-17.916335,"twenty":-94.961194,"median":-85.169245,"eighty":-38.409932,"marketCap":330968465},{"date":"2023-07-14","current":-17.670532,"twenty":-94.842862,"median":-84.784667,"eighty":-37.258425,"marketCap":326427739},{"date":"2023-07-21","current":-21.739944,"twenty":-94.742281,"median":-84.31134,"eighty":-36.079095,"marketCap":401601979},{"date":"2023-07-28","current":-28.062553,"twenty":-94.677198,"median":-83.409061,"eighty":-34.796165,"marketCap":518399540},{"date":"2023-08-04","current":-29.93339,"twenty":-94.286703,"median":-82.536365,"eighty":-32.904256,"marketCap":552959509},{"date":"2023-08-11","current":-26.995861,"twenty":-94.08554,"median":-81.989081,"eighty":-32.668261,"marketCap":618043247},{"date":"2023-08-18","current":-31.292116,"twenty":-93.502756,"median":-80.702223,"eighty":-32.00793,"marketCap":716401699},{"date":"2023-08-25","current":-37.94065,"twenty":-93.221718,"median":-80.156097,"eighty":-32.083886,"marketCap":868613234},{"date":"2023-09-01","current":-40.854587,"twenty":-92.915312,"median":-79.903484,"eighty":-32.320414,"marketCap":935324909},{"date":"2023-09-08","current":-37.500586,"twenty":-92.465023,"median":-79.844318,"eighty":-32.523965,"marketCap":858538410},{"date":"2023-09-15","current":-37.738458,"twenty":-92.121233,"median":-79.42228,"eighty":-32.656553,"marketCap":863984261},{"date":"2023-09-21","current":-36.644245,"twenty":-91.920069,"median":-79.21615,"eighty":-32.731151,"marketCap":838933346},{"date":"2023-09-29","current":-37.881182,"twenty":-91.707013,"median":-77.967511,"eighty":-32.822322,"marketCap":867251771},{"date":"2023-10-06","current":-35.787904,"twenty":-91.647669,"median":-77.231491,"eighty":-32.885998,"marketCap":819328282},{"date":"2023-10-13","current":-37.952543,"twenty":-91.405326,"median":-77.122689,"eighty":-32.951309,"marketCap":868885527},{"date":"2023-10-20","current":-38.475863,"twenty":-91.369827,"median":-76.767694,"eighty":-33.211951,"marketCap":880866399},{"date":"2023-10-27","current":-45.552567,"twenty":-91.34616,"median":-76.665504,"eighty":-33.405497,"marketCap":1042880466},{"date":"2023-11-03","current":-47.146312,"twenty":-91.286994,"median":-75.916538,"eighty":-33.631223,"marketCap":1079367668},{"date":"2023-11-10","current":-46.38512,"twenty":-91.12133,"median":-75.643543,"eighty":-34.145321,"marketCap":1061940945},{"date":"2023-11-17","current":-32.223509,"twenty":-90.866917,"median":-74.864636,"eighty":-33.631223,"marketCap":1012655993},{"date":"2023-11-24","current":-33.118039,"twenty":-90.577004,"median":-74.253145,"eighty":-33.149655,"marketCap":1040767491},{"date":"2023-12-01","current":-36.94712,"twenty":-90.2723,"median":-72.600688,"eighty":-33.116322,"marketCap":1161100195},{"date":"2023-12-08","current":-37.377453,"twenty":-90.227926,"median":-71.520167,"eighty":-33.118039,"marketCap":1174623824},{"date":"2023-12-15","current":-38.791402,"twenty":-90.192426,"median":-66.768665,"eighty":-33.149655,"marketCap":1219058607},{"date":"2023-12-22","current":-39.344687,"twenty":-90.091844,"median":-58.792369,"eighty":-33.34111,"marketCap":1236446131},{"date":"2023-12-29","current":-40.284393,"twenty":-90.020845,"median":-58.76284,"eighty":-33.557154,"marketCap":1265977322},{"date":"2024-01-05","current":-35.752728,"twenty":-89.949846,"median":-58.606145,"eighty":-33.562423,"marketCap":1123565223},{"date":"2024-01-12","current":-40.179005,"twenty":-89.831515,"median":-58.014771,"eighty":-33.5858,"marketCap":1262665413},{"date":"2024-01-19","current":-40.266828,"twenty":-89.713183,"median":-57.705441,"eighty":-33.620497,"marketCap":1265425337},{"date":"2024-01-26","current":-40.38978,"twenty":-89.571185,"median":-57.15493,"eighty":-33.927117,"marketCap":1269289231},{"date":"2024-02-02","current":-39.616938,"twenty":-89.506103,"median":-56.892666,"eighty":-34.392767,"marketCap":1245001896},{"date":"2024-02-09","current":-40.284393,"twenty":-89.381854,"median":-56.610494,"eighty":-34.634958,"marketCap":1265977322},{"date":"2024-02-16","current":-42.155022,"twenty":-89.204356,"median":-56.244496,"eighty":-34.960534,"marketCap":1324763712},{"date":"2024-02-23","current":-41.004541,"twenty":-89.151107,"median":-53.472161,"eighty":-35.087183,"marketCap":1288608702},{"date":"2024-03-01","current":-40.61812,"twenty":-89.015026,"median":-51.278227,"eighty":-35.130626,"marketCap":1276465035},{"date":"2024-03-08","current":-40.907936,"twenty":-88.890777,"median":-47.620083,"eighty":-35.295508,"marketCap":1285572785},{"date":"2024-03-15","current":-34.84258,"twenty":-88.843445,"median":-46.825184,"eighty":-35.130626,"marketCap":1102140477},{"date":"2024-03-22","current":-40.334824,"twenty":-88.748779,"median":-46.658674,"eighty":-35.295508,"marketCap":1275871163},{"date":"2024-03-28","current":-36.796197,"twenty":-88.748779,"median":-46.38512,"eighty":-35.324053,"marketCap":1163937298},{"date":"2024-04-05","current":-35.92997,"twenty":-88.748779,"median":-45.487152,"eighty":-35.288372,"marketCap":1136536821},{"date":"2024-04-12","current":-36.768551,"twenty":-88.719196,"median":-44.612971,"eighty":-35.324053,"marketCap":1163062815},{"date":"2024-04-19","current":-31.884508,"twenty":-88.689613,"median":-42.871015,"eighty":-35.086181,"marketCap":1008570762},{"date":"2024-04-26","current":-35.017668,"twenty":-88.674822,"median":-42.11111,"eighty":-34.84258,"marketCap":1107678872},{"date":"2024-05-03","current":-37.874372,"twenty":-88.630448,"median":-41.895765,"eighty":-34.876769,"marketCap":1198042148},{"date":"2024-05-10","current":-39.164497,"twenty":-88.600865,"median":-41.759818,"eighty":-35.017668,"marketCap":1238851370},{"date":"2024-05-17","current":-37.888556,"twenty":-88.51892,"median":-41.404135,"eighty":-35.036098,"marketCap":1235470034},{"date":"2024-05-24","current":-40.736634,"twenty":-88.45295,"median":-41.099684,"eighty":-35.086181,"marketCap":1328340163},{"date":"2024-05-31","current":-44.543628,"twenty":-88.45295,"median":-41.099684,"eighty":-35.090188,"marketCap":1452478608},{"date":"2024-06-07","current":-44.497942,"twenty":-88.45295,"median":-41.404135,"eighty":-35.150327,"marketCap":1450988887},{"date":"2024-06-14","current":-45.777143,"twenty":-88.452772,"median":-41.634277,"eighty":-35.239068,"marketCap":1492701093},{"date":"2024-06-21","current":-44.698959,"twenty":-88.452654,"median":-41.847641,"eighty":-35.302644,"marketCap":1457543662},{"date":"2024-06-28","current":-42.487768,"twenty":-88.452654,"median":-41.895765,"eighty":-35.316917,"marketCap":1385441134},{"date":"2024-07-05","current":-41.802481,"twenty":-88.435082,"median":-41.839477,"eighty":-35.338325,"marketCap":1363095309},{"date":"2024-07-12","current":-44.726371,"twenty":-88.28398,"median":-41.882771,"eighty":-35.354313,"marketCap":1458437495},{"date":"2024-07-15","current":-44.918251,"twenty":-88.237518,"median":-41.895765,"eighty":-35.356471,"marketCap":1464694326},{"date":"2024-08-02","current":-44.351747,"twenty":-88.191056,"median":-41.90876,"eighty":-35.358629,"marketCap":1446221777},{"date":"2024-08-09","current":-44.991348,"twenty":-88.186704,"median":-42.089284,"eighty":-35.39991,"marketCap":1467077880},{"date":"2024-08-16","current":-43.285824,"twenty":-88.157121,"median":-42.114764,"eighty":-35.450781,"marketCap":1527556714},{"date":"2024-08-23","current":-42.418372,"twenty":-88.038789,"median":-42.159413,"eighty":-35.502817,"marketCap":1496944355},{"date":"2024-08-30","current":-42.036694,"twenty":-88.009206,"median":-42.392349,"eighty":-35.680862,"marketCap":1483474917},{"date":"2024-09-06","current":-42.331627,"twenty":-87.961164,"median":-42.227533,"eighty":-35.680862,"marketCap":1493883119},{"date":"2024-09-13","current":-42.244882,"twenty":-87.926196,"median":-42.240544,"eighty":-35.738355,"marketCap":1490821883},{"date":"2024-09-20","current":-42.114764,"twenty":-87.920457,"median":-42.236207,"eighty":-35.780869,"marketCap":1486230029},{"date":"2024-09-27","current":-40.640097,"twenty":-87.754793,"median":-42.159413,"eighty":-35.892568,"marketCap":1434189019},{"date":"2024-10-04","current":-44.153275,"twenty":-87.678824,"median":-42.155022,"eighty":-35.927723,"marketCap":1558169073},{"date":"2024-10-11","current":-48.056806,"twenty":-87.610073,"median":-42.23187,"eighty":-35.966831,"marketCap":1695924688},{"date":"2024-10-18","current":-48.577277,"twenty":-87.583212,"median":-42.253556,"eighty":-36.082435,"marketCap":1714292104},{"date":"2024-10-25","current":-57.772262,"twenty":-87.56842,"median":-42.340301,"eighty":-36.200338,"marketCap":2038783109},{"date":"2024-10-31","current":-52.524181,"twenty":-87.547712,"median":-42.392349,"eighty":-36.388799,"marketCap":1853578337},{"date":"2024-11-08","current":-71.469319,"twenty":-87.512213,"median":-42.418372,"eighty":-36.504492,"marketCap":2522152258},{"date":"2024-11-15","current":-77.527092,"twenty":-87.440228,"median":-42.474756,"eighty":-36.509518,"marketCap":2561029953},{"date":"2024-11-22","current":-77.072135,"twenty":-87.393881,"median":-42.687282,"eighty":-36.515843,"marketCap":2546000923},{"date":"2024-11-29","current":-59.133818,"twenty":-87.369609,"median":-42.721171,"eighty":-36.559815,"marketCap":1953426542},{"date":"2024-12-06","current":-60.774347,"twenty":-87.336765,"median":-43.285824,"eighty":-36.624404,"marketCap":2007619769},{"date":"2024-12-13","current":-59.236643,"twenty":-87.328799,"median":-43.329196,"eighty":-36.635892,"marketCap":1956823268},{"date":"2024-12-20","current":-59.302077,"twenty":-87.305133,"median":-43.631539,"eighty":-36.657107,"marketCap":1958984822},{"date":"2024-12-27","current":-58.844038,"twenty":-87.269633,"median":-44.153275,"eighty":-36.679484,"marketCap":1943853949},{"date":"2025-01-03","current":-60.535979,"twenty":-87.269633,"median":-44.259567,"eighty":-36.69182,"marketCap":1999745540},{"date":"2025-01-10","current":-52.291271,"twenty":-87.245967,"median":-44.327742,"eighty":-36.706362,"marketCap":1727389832},{"date":"2025-01-17","current":-49.580425,"twenty":-86.930625,"median":-44.488805,"eighty":-36.711576,"marketCap":1637839769},{"date":"2025-01-24","current":-54.40386,"twenty":-86.850153,"median":-44.543628,"eighty":-36.745919,"marketCap":1797177122},{"date":"2025-01-31","current":-55.712544,"twenty":-86.619651,"median":-44.623985,"eighty":-36.76862,"marketCap":1840408187},{"date":"2025-02-07","current":-55.189071,"twenty":-86.451932,"median":-44.726371,"eighty":-36.785185,"marketCap":1823115761},{"date":"2025-02-14","current":-52.880178,"twenty":-86.317195,"median":-44.863428,"eighty":-36.823843,"marketCap":1746843811},{"date":"2025-02-21","current":-53.515825,"twenty":-86.222398,"median":-44.973074,"eighty":-36.860703,"marketCap":1767841757},{"date":"2025-02-28","current":-54.459947,"twenty":-86.204648,"median":-45.320286,"eighty":-36.911857,"marketCap":1799029882},{"date":"2025-03-07","current":-58.848687,"twenty":-86.196539,"median":-45.462383,"eighty":-36.959178,"marketCap":1944007519},{"date":"2025-03-14","current":-66.968572,"twenty":-86.145151,"median":-45.649223,"eighty":-36.982772,"marketCap":2212239805},{"date":"2025-03-21","current":-59.660378,"twenty":-86.06265,"median":-45.720036,"eighty":-36.995041,"marketCap":2156364711},{"date":"2025-03-28","current":-58.885225,"twenty":-86.015317,"median":-46.38512,"eighty":-37.020084,"marketCap":2128347571},{"date":"2025-04-04","current":-56.401211,"twenty":-85.938401,"median":-46.700301,"eighty":-37.071257,"marketCap":2038565369},{"date":"2025-04-11","current":-51.547694,"twenty":-85.825987,"median":-46.789503,"eighty":-37.129042,"marketCap":1863139863},{"date":"2025-04-17","current":-50.455433,"twenty":-85.790487,"median":-47.146312,"eighty":-37.170114,"marketCap":1823661164}],"updateTime":1745093818453}}}